U.S. Markets close in 4 hrs 47 mins

Pfizer Looks Pretty Smart With Array BioPharma Purchase. Here’s Why.

Josh Nathan-Kazis

New results from a colorectal cancer study by Array BioPharma appear to validate Pfizer’s decision last month to acquire the drug company.